The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed at $9.17 down -5.17% from its previous closing price of $9.67. In other words, the price has decreased by -$5.17 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
For a deeper understanding of Tonix Pharmaceuticals Holding Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.78 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.54 while its Price-to-Book (P/B) ratio in mrq is 19.23.
Stock Price History:
Over the past 52 weeks, TNXP has reached a high of $1244.80, while it has fallen to a 52-week low of $9.40. The 50-Day Moving Average of the stock is -66.51%, while the 200-Day Moving Average is calculated to be -90.64%.
Shares Statistics:
A total of 155.63M shares are outstanding, with a floating share count of 5.59M. Insiders hold about 0.00% of the company’s shares, while institutions hold 3.13% stake in the company.
